European Heart Journal: My Cardio Interview: Anthony Tang & Frank Ruschitzka

submitted by: OxfordJournals

Anthony Tang in conversation with Frank Ruschitzka
RAFT: The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

European Heart Journal - My Cardio Interview: Adrian Hernandez & Frank Ruschitzka

submitted by: OxfordJournals

Adrian Hernandez in conversation with Frank Ruschitzka
ASCEND-HF: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial

European Heart Journal - My Cardio Interview: Frank Zannad & Frank Ruschitzka

submitted by: OxfordJournals

Frank Zannad in conversation with Frank Ruschitzka
EMPHASIS-HF: The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure.

European Heart Journal - My Cardio Interview: Otavio Berwanger & Ulf Landmesser

submitted by: OxfordJournals

Otavio Bellwanger in conversation with Ulf Landmesser
ACT: Acetylcystein for the Prevention of Contract-Induced nephropaThy

European Heart Journal - My Cardio Interview: Christoph Kaiser & Thomas Luscher

submitted by: OxfordJournals

Christoph Kaiser in conversation with Thomas Luscher
BASKET PROVE: the BASKET PROspective Evaluation Examination (BASKET PROVE)

European Heart Journal - My Cardio Interview: Stephen Nicholls & Ulf Landmesser

submitted by: OxfordJournals

Stephen Nicholls in conversation with Ulf Landmesser
Results of the First Major Clinical Trial of an Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CVR Risk Modification

European Heart Journal - My Cardio Interview: Peter Kowey & Ulf Landmesser

submitted by: OxfordJournals

Peter Kowey in conversation with Ulf Landmesser
Efficacy and Safety of Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation (AF)

European Heart Journal - My Cardio Interview: William Hiatt & Ulf Landmesser

submitted by: OxfordJournals

William Hiatt in conversation with Ulf Landmesser
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Lib Ischemia – Phase 3 Randomized Double-Blind Placebo-Controlled Trial

European Heart Journal - My Cardio Interview: Christopher Cannon & Ulf Landmesser on DEFINE

submitted by: OxfordJournals

Christopher Cannon in conversation with Ulf Landmesser
DEFINE: Determining the EFficacy and Tolerability of CETP INhibition With AnacEtrapid

European Heart Journal - My Cardio Interview: Peter Sever & Thomas Luscher on ASCOT

submitted by: OxfordJournals

Peter Sever in conversation with Thomas Lüscher
ASCOT: The Anglo-Scandinavian Cardiac Outcomes Trial